Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11075525 | 0.80 | KDM4E (0.67) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL7436133 | 0.78 | — | — | |
| SCHEMBL11079770 | 0.76 | LMNA (0.61) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL7439817 | 0.75 | KDM4E (0.59) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL4787173 | 0.74 | KDM4E (0.58) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL4998752 | 0.72 | KDM4E (0.56) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL193896 | 0.72 | KDM4E (0.56) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL9312505 | 0.72 | CYP2C19 (0.56) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL1352364 | 0.71 | KDM4E (0.55) | LMNAKDM4ECYP2C19TSHRNPSR1 | |
| SCHEMBL9471261 | 0.71 | KDM4E (0.55) | LMNAKDM4ECYP2C19TSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 956 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025010293-A2 | MEK IMMUNE ONCOLOGY INHIBITOR PHARMACEUTICAL COMPOSITIONS | IMMUNEERING CORPORATION (US) | 2025-01-09 | — | — | WO | claimed |
| US-20240350644-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN DER YANG (US) | 2024-10-24 | — | — | US | claimed |
| US-12029792-B2 | Stereocomplexes for the delivery of anti-cancer agents | TIEN DER YANG (US) | 2024-07-09 | — | — | US | claimed |
| CN-113727985-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-04-16 | — | — | CN | claimed |
| US-20230405018-A1 | FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS | BEXSON BIOMEDICAL, INC. | 2023-12-21 | — | — | US | claimed |
| US-20230398197-A1 | COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN | UNIVERSITY OF IDAHO (US) | 2023-12-14 | — | — | US | claimed |
| US-20230395255-A1 | METHODS FOR IDENTIFYING AND TARGETING THE MOLECULAR SUBTYPES OF ALZHEIMER'S DISEASE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2023-12-07 | — | — | US | claimed |
| EP-4247386-A1 | FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS | Bexson Biomedical, Inc. (US) | 2023-09-27 | — | — | EP | claimed |
| CN-115323060-B | Fish nuclear gene molecular marker primer, molecular marker and molecular marker database | 中国水产科学研究院珠江水产研究所 | 2023-08-01 | — | — | CN | claimed |
| EP-4137527-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN, Der-Yang (US) | 2023-02-22 | — | — | EP | claimed |
| WO-2001001932-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2001-01-11 | — | — | WO | claimed |
| WO-2000059481-A1 | PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT | PHARMAQUEST LTD. (BM) | 2000-10-12 | — | — | WO | claimed |
| WO-2000059479-A1 | PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF METHYLPHENIDATE | PHARMAQUEST LTD. (BM) | 2000-10-12 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| CN-2329059-Y | Quick look-up instrument for incompatibility of drugs in a prescription of 159 kind of injections | GU CHUNWEI (CN) | 1999-07-14 | — | — | CN | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| EP-0110955-B1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIV FLORIDA (US) | 1995-08-23 | — | — | EP | claimed |
| EP-0224283-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-06-03 | — | — | EP | claimed |
| EP-0222425-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-05-20 | — | — | EP | claimed |
| EP-0218300-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-04-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230405018-A1 | FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS | GABBR1, GABBR2, GABRB2 | LMNA 4363/4885KDM4E 3062/4885CYP2C19 331/4885 |
| US-12029792-B2 | Stereocomplexes for the delivery of anti-cancer agents | TOP2A, TSG101, TOP1 | LMNA 2051/4885KDM4E 4639/4885CYP2C19 4324/4885 |
| US-20240350644-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TOP2A, TSG101, TOP1 | LMNA 2051/4885KDM4E 4639/4885CYP2C19 4324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.